Yizhou Li Selected Research

Yizhou Li Research Topics

Disease

6	Neoplasms (Cancer) 04/2022 - 06/2016
3	Fibrosis (Cirrhosis) 05/2022 - 09/2021
3	Obesity 09/2021 - 01/2021
2	Vascular Calcification 12/2016 - 06/2016
2	Neoplasm Metastasis (Metastasis) 12/2016 - 06/2016
2	Osteonecrosis (Kienbock's Disease) 12/2016 - 01/2015
1	Osteosarcoma (Osteogenic Sarcoma) 04/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2021
1	Body Weight (Weight, Body) 09/2021
1	Inflammation (Inflammations) 09/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 07/2020
1	Tics (Tic) 01/2019
1	Degloving Injuries 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Carcinogenesis 01/2019
1	Photosensitivity Disorders (Photodermatitis) 11/2018
1	Necrosis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2016
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 01/2015
1	Stroke (Strokes) 01/2015
1	Sepsis (Septicemia) 01/2015
1	Drug-Related Side Effects and Adverse Reactions 01/2014

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2018
3	LeptinIBA 05/2022 - 09/2021
3	Pharmaceutical PreparationsIBA 07/2020 - 01/2014
2	Caspase 3 (Caspase-3)IBA 04/2022 - 01/2019
2	IntegrinsIBA 11/2021 - 09/2021
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	OsteoprotegerinIBA 12/2016 - 06/2016
1	Sorafenib (BAY 43-9006)FDA Link 04/2022
1	Histone Deacetylase InhibitorsIBA 04/2022
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 04/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2021
1	WortmanninIBA 11/2021
1	Hematoxylin (Haematoxylon)IBA 11/2021
1	Phosphotransferases (Kinase)IBA 11/2021
1	Complement System Proteins (Complement)IBA 10/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	LipidsIBA 09/2021
1	N-methyladenosineIBA 09/2021
1	6-methyladenineIBA 09/2021
1	CollagenIBA 09/2021
1	X-Box Binding Protein 1IBA 09/2021
1	STF 083010IBA 09/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021
1	Interleukin-6 (Interleukin 6)IBA 09/2021
1	Nimodipine (Modus)FDA LinkGeneric 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	EnzymesIBA 01/2021
1	CytokinesIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	LignansIBA 08/2020
1	AntioxidantsIBA 08/2020
1	Biological ProductsIBA 07/2020
1	Antimitotic AgentsIBA 07/2020
1	TubulinIBA 07/2020
1	Actins (F Actin)IBA 07/2020
1	NickelIBA 01/2019
1	PalladiumIBA 01/2019
1	titanium carbideIBA 01/2019
1	2,4-dichlorobenzoic acidIBA 01/2019
1	2',4'-dichlorobenzamil amiloride (DCBA)IBA 01/2019
1	SolutionsIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Coloring Agents (Dyes)IBA 11/2018
1	Anthocyanins (Anthocyanin)IBA 11/2018
1	Serum AlbuminIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Horseradish PeroxidaseIBA 01/2018
1	AcidsIBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	human TNKS proteinIBA 01/2018
1	Carbonic Anhydrase IXIBA 01/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018
1	Circular RNAIBA 01/2017
1	RANK LigandIBA 06/2016
1	NucleotidesIBA 03/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	ApolipoproteinsIBA 01/2015
1	Apolipoproteins B (ApoB)IBA 01/2015
1	Terazosin (Hytrin)FDA LinkGeneric 01/2015

Therapy/Procedure

2	Therapeutics 04/2022 - 01/2021
1	Oral Administration 04/2022
1	Aftercare (After-Treatment) 09/2021
1	Orthopedic Procedures 03/2021
1	Radiotherapy 01/2019